N/A
N=512
Refining the Shared Decision Making Process Survey in ADHD Medication Decisions
ADHD
Bottom Line
View on ClinicalTrials.gov: NCT05048186 ↗Enrolled (actual)
512
Serious AEs
0.0%
Results posted
Nov 2024
Primary outcome: Primary: Shared Decision Making Process Score — 2.83; 2.77 units on a scale — p=0.503
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- Attention Deficit Hyperactivity Disorder Treatment Decision Aid (Behavioral)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Massachusetts General Hospital
- Primary completion
- Mar 2021
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Shared Decision Making Process Score |
2.83; 2.77 | 0.503 |
| SECONDARY ADHD Knowledge |
68.37; 59.9 | — |
| SECONDARY Decisional Conflict Tool (SURE) |
164; 184 | — |
| SECONDARY Single-item Measure of Decision Regret |
100; 102; 116; 123; 18; 25 | — |
| SECONDARY Treatment Choice |
151; 146; 91; 110 | — |
| SECONDARY National Initiative for Children's Healthcare Quality (NICHQ) Vanderbilt Assessment Performance Sub-scale |
22.46; 21.07 | — |
| SECONDARY Adapted Controlled Preference Scale |
109; 119; 22; 27; 108; 110 | — |
| SECONDARY Shared Decision Making Process Measure Retest |
2.84; 2.60 | — |
Summary
This is a retrospective observational survey study. We will survey a sample of adult parents or legal guardians who have a child who has been diagnosed with Attention Deficit Hyperactivity Disorder (ADHD) and who discussed ADHD treatment options for their child with a health care provider within the last 2 years. The main goal is to gather evidence of the validity and reliability of the Shared Decision Making Process scale. Secondary goal is to gather evidence on the quality of decisions parents make about their children with ADHD. A third goal is to assess the impact of a Decision Aid on participant knowledge of ADHD treatment options. Participants will be randomized to one of two arms: participants in the intervention arm will review a Decision Aid (patient educational tool) partway through the survey and those in the control arm will not receive any educational materials. All participants will complete survey that includes the Shared Decision Making process survey along with a few other measures. A subset of respondents will also complete a retest survey about two weeks after the initial survey.
Eligibility Criteria
Inclusion Criteria
- Adult parent or legal guardian of a child between the ages of 5 and 13 who has been diagnosed with Attention Deficit Hyperactivity Disorder (ADHD)
- Read English
- Have talked with a health care provider about medication for treatment of ADHD for the child in the past 2 years
Exclusion Criteria
- None
Data sourced from ClinicalTrials.gov (NCT05048186). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.